Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence.
Cutrona G, Tripodo C, Matis S, Recchia AG, Massucco C, Fabbi M, Colombo M, Emionite L, Sangaletti S, Gulino A, Reverberi D, Massara R, Boccardo S, de Totero D, Salvi S, Cilli M, Pellicanò M, Manzoni M, Fabris S, Airoldi I, Valdora F, Ferrini S, Gentile M, Vigna E, Bossio S, De Stefano L, Palummo A, Iaquinta G, Cardillo M, Zupo S, Cerruti G, Ibatici A, Neri A, Fais F, Ferrarini M, Morabito F. Cutrona G, et al. Among authors: fabbi m. Sci Transl Med. 2018 Feb 14;10(428):eaal1571. doi: 10.1126/scitranslmed.aal1571. Sci Transl Med. 2018. PMID: 29444977
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
de Totero D, Meazza R, Zupo S, Cutrona G, Matis S, Colombo M, Balleari E, Pierri I, Fabbi M, Capaia M, Azzarone B, Gobbi M, Ferrarini M, Ferrini S. de Totero D, et al. Among authors: fabbi m. Blood. 2006 May 1;107(9):3708-15. doi: 10.1182/blood-2005-09-3535. Epub 2006 Jan 3. Blood. 2006. PMID: 16391014 Free article.
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells.
Matis S, Grazia Recchia A, Colombo M, Cardillo M, Fabbi M, Todoerti K, Bossio S, Fabris S, Cancila V, Massara R, Reverberi D, Emionite L, Cilli M, Cerruti G, Salvi S, Bet P, Pigozzi S, Fiocca R, Ibatici A, Angelucci E, Gentile M, Monti P, Menichini P, Fronza G, Torricelli F, Ciarrocchi A, Neri A, Fais F, Tripodo C, Morabito F, Ferrarini M, Cutrona G. Matis S, et al. Among authors: fabbi m. Blood Adv. 2022 Oct 25;6(20):5593-5612. doi: 10.1182/bloodadvances.2021005726. Blood Adv. 2022. PMID: 35819446 Free PMC article. Clinical Trial.
Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL.
Morabito F, Cutrona G, Gentile M, Fabbi M, Matis S, Colombo M, Reverberi D, Megna M, Spriano M, Callea V, Vigna E, Rossi E, Lucia E, Festini G, Zupo S, Molica S, Neri A, Ferrarini M. Morabito F, et al. Among authors: fabbi m. Br J Haematol. 2010 Apr;149(1):160-3. doi: 10.1111/j.1365-2141.2009.08032.x. Epub 2009 Dec 8. Br J Haematol. 2010. PMID: 19995391 Free article. No abstract available.
A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells.
Gugiatti E, Tenca C, Ravera S, Fabbi M, Ghiotto F, Mazzarello AN, Bagnara D, Reverberi D, Zarcone D, Cutrona G, Ibatici A, Ciccone E, Darzynkiewicz Z, Fais F, Bruno S. Gugiatti E, et al. Among authors: fabbi m. Haematologica. 2018 Nov;103(11):e531-e536. doi: 10.3324/haematol.2017.175414. Epub 2018 Jun 21. Haematologica. 2018. PMID: 29930162 Free PMC article. No abstract available.
168 results